Crinetics Pharmaceuticals, Inc. (CRNX) — Analysis Summary
Crinetics Pharmaceuticals, Inc. (CRNX) has a market cap of $4.11B with year-over-year revenue growth of -74.1%. Net margin stands at -28720.7%. The stock trades at a P/E ratio of -13.8.
Key Takeaways
- Revenue changed -74.1% year-over-year
- Net margin of -28720.7%
- P/E ratio of -13.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, CRNX posted revenue growth of -74.1% and trades at a P/E of -13.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.